LINC01704: A Potential Drug Target and Biomarker (G646268)

Target Name: LINC01704

NCBI ID: G646268

LINC01704

Other Name(s): long intergenic non-protein coding RNA 1704 | Long intergenic non-protein coding RNA 1704 | hCG1654703

LINC01704: A Potential Drug Target and Biomarker

LINC01704 is a long intergenic non-protein coding RNA (lncRNA) that has been identified as a potential drug target or biomarker. It is located on chromosome 6p12 and has a length of 292 nucleotides.

LINC01704 is a non-coding RNA molecule that is involved in the regulation of gene expression. It is expressed in a variety of tissues and cells, including the brain, heart, and testes. It has been shown to play a role in the development and progression of several diseases, including cancer, neurodegenerative diseases, and autoimmune diseases.

One of the reasons why LINC01704 is considered a potential drug target is its unique structure and location on the genome. LINC01704 is a long RNA molecule that is predominantly transcribed from the intron of a gene that is located on chromosome 6p12. This means that it is not a short-lived RNA molecule, as many drug targets are. Additionally, LINC01704 is located in a region of the genome that is known for the presence of drug targets, such as gene promoters that are targeted by drugs.

Another potential reason why LINC01704 is a drug target is its function in the regulation of gene expression. LINC01704 has been shown to play a role in the regulation of gene expression by binding to specific DNA sequences and influencing the activity of RNA polymerase. This means that LINC01704 may be a good candidate for drugs that target the regulation of gene expression.

In addition to its potential as a drug target, LINC01704 may also be a useful biomarker for certain diseases. For example, LINC01704 has been shown to be expressed in several types of cancer, including breast, ovarian, and prostate cancer. This suggests that it may be a useful biomarker for these types of cancer. Additionally, LINC01704 has also been shown to be expressed in neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease. This suggests that it may be a useful biomarker for these types of diseases as well.

Overall, LINC01704 is a promising candidate for drug targeting and biomarker research. Its unique structure and location on the genome, as well as its function in the regulation of gene expression, make it a valuable tool for the study of these diseases. Further research is needed to fully understand the potential of LINC01704 as a drug target and biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1704

The "LINC01704 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01704 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets